CHAD ELLIS: Open Payments
NPI 1154889996 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 92 payments from 23 companies in 2025. Trend: 2023 $1,752 · 2024 $1,356 · 2025 $1,986
Food & beverage: $1,972Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 20 | $465 |
| Gilead Sciences, Inc. | 23 | $415 |
| Amgen Inc. | 9 | $216 |
| AstraZeneca Pharmaceuticals LP | 10 | $213 |
| Dentsply Sirona Inc | 1 | $114 |
| ABBVIE INC. | 4 | $78 |
| Abbott Laboratories | 3 | $65 |
| Lilly USA, LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $49 |
Products named: CABENUVA, Primescan Connect, DOVATO, FARXIGA, AIRSUPRA, APRETUDE, KRYSTEXXA, CAPLYTA.
Industry payments across NC — which companies pay providers there.
